Analysis of the factors affecting the formation of the microbiome associated with chronic osteomyelitis of the jaw  by Goda, A. et al.
Analysis of the factors affecting the formation of the microbiome
associated with chronic osteomyelitis of the jaw
A. Goda1*, F. Maruyama2,3*, Y. Michi1, I. Nakagawa2 and K. Harada1
1) Section of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 2) Section of Bacterial Pathogenesis,
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University and 3) Section of Microbial Genomics and Ecology, Graduate School of
Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
Abstract
Chronic osteomyelitis of the jaw (COMJ) is one of the most intractable diseases among head and neck infections. Antimicrobial agents are
routinely administered for COMJ without sufﬁcient bacterial information, resulting in frequent treatment failures. To improve our
knowledge of the bacterial aetiology of COMJ and to assist in the development of effective treatments, we performed a comprehensive
analysis of the microbiome. Sixteen patients with four clinical types of COMJ (four with suppurative osteomyelitis, three with
osteoradionecrosis of the jaw, four with primary chronic osteomyelitis, and ﬁve with bisphosphonate-related osteonecrosis of the jaw)
were enrolled in this study. Bone samples were subjected to bacterial community comparisons by 16S rRNA gene pyrosequencing. As a
result, we clariﬁed that COMJ was caused by a far greater range of bacterial species (12 phyla and 163 genera) than previously reported.
Moreover, the bacterial structures in COMJ changed dramatically with disease stage and the condition of the affected bone. Multiple
correlation analyses revealed that sequestration and bone exposure could affect the community structure. On the basis of these factors, we
reclassiﬁed COMJ into three clinical stages: I, inﬂamed or sclerotic bone without exposure; II, sequestrum without exposure; and III,
exposed sequestrum. In stage II, the bacterial diversity was signiﬁcantly lower, and the anaerobe genera Fusobacterium, Tannerella (formerly
Bacteroides) and Porphyromonas were more abundant, than observed during other stages. Because these bacteria habitually reside in any
clinical stage, they were considered to constitute the core microbiome of COMJ. Targeting these bacteria should lead to the development
of effective preventive measures and cures.
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Introduction
In spite of improvements in dental and medical care, osteo-
myelitis of the jaw is still a common disease [1]. The
introduction of antibiotics has decreased the threat of acute
osteomyelitis of the jaw, but relapses and persistent chronic
osteomyelitis of the jaw (COMJ) are still concerns for clinicians
[2].
COMJ is classiﬁed into various types on the basis of their
clinical characteristics. According to the Zurich classiﬁcation
system [1], COMJ can be divided into primary COMJ (PCO)
and secondary COMJ. Secondary COMJ is further subclassi-
ﬁed into three major clinical types: suppurative chronic
osteomyelitis (SUP), osteoradionecrosis of the jaw (ORN),
and bisphosphonate-related osteonecrosis of the jaw
(BRONJ). The name suppurative chronic osteomyelitis is
derived from the major symptoms of this COMJ type;
namely, abscess/pus formation, sequestration, and exposed
bone [1]. The hypothesized major aetiology is deep bacterial
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invasion of the medullar and cortical bone by odontogenic
infection and/or extraction wounds and bone fracture [1,3].
ORN is caused by head and neck radiation therapy, and
BRONJ is thought to be induced by the administration of
bisphosphonate drugs for the treatment of osteoporosis;
both of these conditions have been well described in the
literature [4,5]. These two types of secondary COMJ result in
symptoms similar to those of SUP, caused by secondary
bacterial infection of the affected bone [1]. On the other
hand, patients who presented with non-suppurative chronic
inﬂammation of the jawbone, with the absence of causative
dental infection, pus formation, ﬁstula formation, or seques-
tration, were diagnosed as having PCO [6]. In addition,
recurrent pain, swelling, trismus and diffuse sclerosis in
radiographic ﬁndings have also been used as diagnostic
criteria for PCO, but the aetiology of this type of COMJ is
not fully understood.
The general treatment for osteomyelitis involves surgical
treatment (such as sequestrectomy or cortical osteotomy)
combined with antimicrobial therapy or antimicrobial mono-
therapy [1,7]. However, current antibiotic treatments are
empirically introduced, with little information on the target
bacterial species, and, in many cases, bacteria are resistant to
conventional surgical and antimicrobial therapies [2]. There-
fore, a comprehensive bacterial investigation is required.
Although some studies have investigated the bacterial com-
munities associated with COMJ [8–12], most of these have
used only culture-dependent methods. Most of the infectious
diseases in the oral and maxillofacial regions are caused by
polymicrobial infection of anaerobes [9], and all of the
causative bacteria may not be culturable with the methods
used in previous reports. Recently, a few studies have
reported using molecular techniques based on the 16S rRNA
gene [13,14], which are therefore culture-independent.
However, no reports have described the use of high-through-
put sequencers, which enable us to obtain far more
substantial information about the bacterial community of
COMJ than previously applied techniques, such as clone
library sequencing methods. In addition, the causative bacte-
rial species can be different, and comparisons of bacterial
communities should be conducted among various clinical
types of COMJ, as the different clinical types show different
clinical characteristics. Therefore, to determine the bacterial
species related to the aetiology of COMJ, which could lead to
future effective treatments for this disease, we applied
high-throughput sequencing [15] to obtain sufﬁcient informa-
tion for analysis of the bacterial communities. Additionally,
we conducted analyses of the four clinical types of COMJ
(SUP, ORN, BRONJ, and PCO).
Materials and Methods
Patients and sample collection
Samples were collected from 20 patients diagnosed with
COMJ on the basis of clinical and radiographic ﬁndings [1], and
who had undergone surgical treatment for COMJ at Tokyo
Medical and Dental University (TMDU) Hospital Faculty of
Dentistry between January and September 2012. Patients with
uncontrolled diabetes and those taking steroids and anticancer
drugs were excluded from the study, resulting in a ﬁnal total of
16 patients being enrolled for further investigation.
These 16 patients were classiﬁed into the four major clinical
types on the basis of clinical and radiographic ﬁndings [1]: four
with SUP, three with ORN, four with PCO, and ﬁve with
BRONJ.
All patients had undergone sequestrectomy or cortical
osteotomy under local or general anaesthesia with either an
intra-oral or an extra-oral approach. A part of the obtained
sample was promptly storted at 80°C, and the remaining
sample was subjected to histopathological tests, which were
used to diagnose the samples as osteomyelitis or sequestrum.
This study was approved by the TMDU Institutional Review
Board (approval number: 732), and voluntary informed
consent was obtained from all of the patients enrolled.
DNA extraction and PCR ampliﬁcation
The detailed experimental protocol of this section is given in
Data S1.
After DNA extraction from the samples, PCR ampliﬁcation
of the V3–V4 region of the 16S rRNA gene was carried out
with bacterial universal primers 338F and 806R [16], which
contained the 30-mer 5′-end adapter sequence required for
the 454 GS Junior Sequencing System (Roche Diagnostics,
Basel, Switzerland) and 10-bp barcodes, for each sample, to
distinguish the PCR products from different samples in the
same sequencing run.
Pyrosequencing and data analysis
Puriﬁed and quantiﬁed amplicons were mixed in equal
amounts, and the mixed libraries were sequenced by use of
the 454 GS Junior Sequencing System, according to the
manufacturer’s instructions. The sequences obtained in this
study are available at the DDBJ Sequence Read Archive
(accession number: DRA000916). The sequence data were
processed and analysed with the open-source software for
bacterial community analysis, Mothur version 1.27 [17]. The
de-noising, ﬁltering of low-quality reads, trimming of the
barcode sequences, alignment against the SILVA 16S rRNA
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database [18] and detection of chimeras with UCHIME [19]
were carried out according to standard operational proce-
dures (http://www.mothur.org/wiki/Schloss_SOP; accessed 1
September 2012). All sequences were clustered into species-
level operational taxonomic units (OTUs) at the 3% dissim-
ilarity cut-off, by use of the average neighbour algorithm. Each
OTU was assigned taxonomy to the genus level, with a naive
Bayesian classiﬁer provided by the Ribosomal Database Project
(RDP classiﬁer) at a conﬁdence threshold of 0.8 [20]. This
classiﬁer uses a posteriori probability to identify a query
sequence on the basis of the occurrence of eight-base
subsequences (words) in their Mothur version of the rRNA
reference ﬁle [17]. For the species-level assignment, a BLASTN
search against the curated database of oral 16S rRNA
sequences, CORE [21], was also carried out. Sequences
showing at least 98.5% sequence similarity over at least 300 bp
were assigned to each species. The remaining unassigned
sequences were subjected to a BLASTN search against non-
redundant SILVA 16S rRNA datasets [18]. Results of the Gram
staining and oxygen requirement assays for each taxon were
obtained from the NCBI Entrez Genome Project database
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi; accessed 1
September 2012). To evaluate the sequence coverage (i.e.
the percentage of sequenced species of total species repre-
sented in a sample), we calculated Good’s coverage
(= (1  (n/N)) 9 100; where n is the number of OTUs that
have been sampled once, and N is the total number of
sequences in the sample) [22]. Because some alpha-diversity
indexes were strongly affected by the original sample size [23],
and the number of obtained reads was different between
samples, the reads were subsampled into the smallest number.
Alpha-diversity indices, the observed number of OTUs and
Chao1 [24] were estimated to determine the species richness
(the number of species), and the Shannon index [25] was
estimated to determine the species diversity (a concept that
includes species richness and species evenness, which means
the relative abundances of the different species). Rarefaction
curves [26] were also used to assess the species richness, by
plotting the estimated number of OTUs as a function of the
number of individuals sampled. Community distances between
each sample were calculated by unweighted UniFrac [27], and
the generated distance matrix was visualized with principal
coordinate analysis [28] and UPGMA clustering [29]. Analysis
of molecular variance [30] was used to test the bacterial
diversity within two populations, in order to determine the
signiﬁcant differences. The relative abundance of OTUs that
were differentially distributed between populations was
statistically evaluated with Metastats [31] in the Mothur
software. Statistical analysis was performed with R software
version 2.15.1 (http://www.r-project.org).
Results
Characteristics of patients and obtained sequences
The 16 patients included in this study consisted of four men
(25.0%) and 12 women (75.0%). Patient ages ranged from 47 to
85 years (average, 66.6 years). Three samples were from the
maxilla (18.8%), and 13 samples were from the mandible
(81.2%). Detailed patient information is summarized in
Tables S1 and S2, including the use of antimicrobial agents,
tooth extraction, discharge of pus, presence of bone exposure,
surgical procedure, results of histopathological inspections of
lesions. A total of 140 955 reads were obtained from the
pyrosequencing. After processing to obtain high-quality
sequences, 116 519 reads were used for further analysis.
The number of reads for each sample ranged from 2461 to
17 813 (average, 7282; Table S3), with an average length of
350 bp. Because the average value of Good’s coverage was
99.02%, the obtained reads in the samples were regarded as
sufﬁcient for analysis of bacterial composition (Table S3).
Phylogenetic distribution of bacteria and species diversity in
each sample
An overview of the phylogenetic composition at the phylum
level is shown in Fig. 1. Twelve phyla were identiﬁed, among
which the Bacteroidetes, Firmicutes, Fusobacteria and Actinobac-
teria were detected in all samples. The phyla Chloroﬂexi, SR1
and Deinococcus-Thermus were detected only in samples from
SUP, PCO, and ORN, respectively.
From the estimation of species richness and diversity for all
samples, the observed number of OTUs varied greatly for each
sample (from 10 to 165; average, 79.25; Table S3). Other
diversity indices (Chao1 and Shannon) of species richness and
evenness also showed large differences among the samples
(Fig. S1). Even within the same clinical type, high inter-individ-
ual diversity was observed, but we could not ﬁnd differences
between the clinical types.
Multiple regression analysis and classiﬁcation based on the
interrelated factors
We hypothesized that the species diversity may be affected by
various clinical parameters other than clinical type. Therefore,
we performed multiple regression analysis between the
Shannon indices or the number of OTUs and clinical param-
eters, and the results are shown in Table S4. From the analysis,
both bone exposure and sequestration (p <0.05 for both)
were selected as factors affecting the Shannon indices and the
number of OTUs (Table S4), but we could not ﬁnd any
correlation between the other parameters, such as the use of
antibiotics and the species diversity. Interestingly, these factors
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were closely related to disease progression, indicating that the
bacterial composition varies with the progression of osteo-
myelitis. Therefore, we reclassiﬁed all of the samples into
three clinical stages on the basis of these two factors: stage I,
inﬂamed or sclerotic bone without exposure; stage II, seques-
trum without exposure; and stage III, exposed sequestrum
(Table 1).
Comparison of species diversity and community structure
between different clinical stages
According to our newly deﬁned clinical stages, the species
richness was compared again on the basis of the number of
OTUs (Fig. 2a). Stage II samples showed signiﬁcantly smaller
richness than the other stages (p <0.05; Mann–Whitney
U-test), and the result was consistent with the rarefaction
curve (Fig. 2b). In addition, the decrease in species diversity
observed in stage II samples was also conﬁrmed by the Chao1
and Shannon indices (Fig. S1).
To compare the community structures of the different
clinical stages, the distances between communities were
calculated by unweighted UniFrac and visualized with principal
coordinate analysis plots. No clusters within each clinical type
were observed (Fig. S2a), but a clear correlation was observed
according to clinical stage (Fig. S2b). UPGMA analysis also
showed a clear clustering of stage II samples (Fig. S2c).
Analysis of molecular variance tests against the unweighted
UniFrac distances revealed that the community structures of
the samples in stage II were signiﬁcantly different from those
of the other two stages (p <0.05; Fig. S2b).
Therefore, the bacterial composition observed in osteo-
myelitis was signiﬁcantly affected by the clinical stage, but not
by the clinical type. In particular, a clear decrease in species
richness and changes in community composition were
observed in the stage II samples, which formed sequestrum
under mucous membranes.
TABLE 1. Classiﬁcation of bone specimens on the basis of
diseased site condition
Clinical stage Sequestration
Bone
exposure Sample IDs
Stage I No No P1, P10, P21, P22,
S8, S11, S12Inﬂamed or sclerosing
bone without exposure
Stage II Yes No S9, B14, B15, B18
Sequestrum covered
with mucous membrane
Stage III Yes Yes B17, B19, O2, O6,
O13Exposed sequestrum
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FIG. 1. Relative abundance of phyla in the chronic osteomyelitis of the jaw microbiome. For the initial comparison of community structures, each
operational taxonomic unit was assigned taxonomy to a genus level, and the relative abundance of each taxon (phylum level) within samples was
calculated. Percentages of all samples (a) and groups by clinical type (b) are shown. BRONJ, bisphosphonate-related osteonecrosis of the jaw; ORN,
osteoradionecrosis of the jaw; PCO, primary chronic osteomyelitis of the jaw; SUP, suppurative chronic osteomyelitis.
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Phylogenetic composition of bacteria in each clinical stage
Next, we performed detailed comparisons of the bacterial
species in each clinical stage. Within the total of 612 OTUs, 12
phyla and 163 genera were found. Twenty-nine of the 32
genera found in stage II were commonly found in both stage I
and stage III (Fig. 4c), but these genera were differentially
distributed (Fig. 3). The genera Fusobacterium (26.9%), Tanne-
rella (18.0%), Porphyromonas (11.8%), Treponema (9.4%) and
Parvimonas (9.1%) were dominant in stage II. On the other
hand, Prevotella (13.6%), Fusobacterium (13.1%), Streptococcus
(13.0%) and Methylobacterium (7.8%) were dominant in stage I,
and Prevotella (27.7%), Fusobacterium (14.2%), Actinomyces
(7.8%) and Porphyromonas (7.8%) were dominant in stage III.
To identify the characteristics of the constituent species in
each stage, 56 OTUs that dominated each stage (relative
abundance, ≥0.5%) were classiﬁed into species-level taxa with
BLAST searches (Fig. S3), and comparisons of their oxygen
requirements and Gram staining status were performed
(Fig. 4a,b). At ﬁrst, within the relatively abundant 56 OTUs,
46 OTUs (82.1%) were anaerobic and 14 OTUs (25%) were
known as unculturable bacteria. In stage I, the abundance of
aerobic bacteria was higher than in the other stages (p <0.05,
Mann–Whitney U-test). In stage II, almost no aerobic bacteria
were found, and the abundance of anaerobic bacteria was
statistically higher than in the other stages (p <0.05, Mann–
Whitney U-test). Most of the bacteria in stage II were
Gram-negative anaerobes (p <0.05, Mann–Whitney U-test)
such as Fusobacterium nucleatum, and important periodontal
pathogens with many virulence factors such as Porphyromonas
gingivalis and Tannerella forsythia.
Within 29 shared genera, 38 species-level OTUs were
shared among the three stages (Fig. 4c,d). Although all of these
species were not commonly detected in all of the samples,
given their nature, these members could be key players in
establishing refractory pathogenic conditions, and were thus
regarded as the core microbiome of COMJ (Fig. 4e).
Discussion
In previous studies using the 16S rRNA Sanger sequencing
method, the existence of seven to nine phyla was conﬁrmed in
BRONJ [13,14]. In this study using pyrosequencing, ﬁve phyla
(Synergistetes, Tenericutes, Chloroﬂexi, SR1, and Deinococcus-Ther-
mus) that have never been reported were newly detected
(Fig. 1). Because these phyla were not abundant, the results
can be explained by the fact that they were missed in previous
studies, owing to the small number of sequences. In addition,
all 16 samples, including four PCO samples, were thought to
include diverse bacterial species, although the involvement of
bacteria in PCO has not been clearly demonstrated in previous
studies using culture and Sanger methods [32]. Because no
ﬁstula or bone exposure was shown in PCO, and all operations
were performed extra-orally, contamination by biomaterials
such as saliva was unlikely to occur; thus, haematogenous
infection from adjacent odontogenic foci or other focal
infections could be the cause. Moreover, within the relatively
abundant 56 OTUs (≥0.5%), >80% of bacteria were anaerobic,
and 25% of them were known to be unculturable bacteria.
These results indicated that COMJ was not caused by single or
limited pathogens, as indicated from the results of previous
culture and/or microscopic methods, but by diverse bacteria
comprising both aerobic and anaerobic species, including
unculturable bacteria.
This study compared, for the ﬁrst time, the microbial
compositions of four different clinical types of COMJ, using
culture-independent methods. Because there is no standard-
ized sampling protocol for investigating the microbiome of
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FIG. 2. Comparison of species diversity between clinical stages. The observed number of operational taxonomic units (OTUs) (an estimator of
richness) in each sample was plotted with respect to clinical stage (a; *p <0.05, **p <0.01, Mann–Whitney U-test; error bars indicate 95% CIs).
Rarefaction curves are shown for each sample (b).
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target tissues such as pus, soft tissues, or bone, a comparison
of the microbiome among different clinical types of COMJ
from different studies was difﬁcult [1]. In addition, investigation
of the microbiome with pus samples was reported to be
inappropriate for identiﬁcation of the causative bacteria of
osteomyelitis, and studies therefore recommended that bone
samples be used [33]. Therefore, this study was limited to the
use of bone samples removed surgically. However, the
bacterial compositions obtained here were diverse, and the
community structures varied widely, even in the same clinical
types, resulting in the absence of clusters for any clinical type
(Figs 1 and S2a). The number of total COMJ samples in this
study was relatively high as compared with previous cul-
ture-independent studies of COMJ, but this study was limited,
because of its small sample size, for the comparison of each
clinical type. On the other hand, the analysis of the clinical
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FIG. 3. Taxonomy-based comparison (genus level) between clinical stages. The relative abundance of each taxon (genus level) within samples is
shown (mean  standard error of the mean). The abundant taxa (relative abundance, ≥0.5%) in each clinical stage were sorted according to the
magnitude of the difference. The signiﬁcance of the differences between clinical stages was detected with the Mothur Metastats command (*p <0.05,
**p <0.01): (a) stage I vs. stage II; (b) stage III vs. stage II; (c) stage I vs. stage III.
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metadata revealed that the microbial composition in osteo-
myelitis of the jaw was signiﬁcantly affected by the state of the
bone or the clinical stage (Fig. S2b). It is well known that
bacterial compositions shift with the clinical stage of diseases,
e.g. in dental caries, where the bacterial diversity decreases
with disease progression [34]. In this study, the clear decrease
in diversity during the formation of sequestrum (Fig. 2a,b)
appeared to be a result of the host immune defence, changes in
oxygen conditions of the lesion caused by ischaemia, and the
fact that only a small number of bacteria that tolerated the
anaerobic and limited nutrient conditions were able to
persistently infect the tissue. In fact, almost no aerobes were
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FIG. 4. Comparison of Gram staining, oxygen requirements and shared taxa between clinical stages. (a, b) The overall abundance of Gram-positive
or Gram-negative aerobic (a) and Gram-positive or Gram-negative anaerobic (b) bacteria for abundant operational taxonomic units (OTUs) (relative
abundance, >0.5%) in each clinical stage (*p <0.05, **p <0.01, Mann–Whitney U-test, mean  standard error of the mean (SEM)). (c) Venn diagram
showing the number of shared taxa at the genus level in each clinical stage. Twenty-nine of 163 genera were commonly observed in all clinical stages.
(d) The shared 29 genera included a total of 316 species-level OTUs. Thirty-eight of these OTUs were commonly detected at all clinical stages. (e) A
total of 38 commonly observed OTUs in all the clinical stages were classiﬁed into species-level taxa with BLAST searches, and arranged by the overall
abundance of each OTU at each clinical stage (mean  SEM).
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detected at stage II (Fig. 4a), and only some anaerobes, such as
members of Porphyromonas and Tannerella, were able to evade
the host immune system [35,36].
We also revealed the core microbiome of COMJ (Fig. 4e).
Of these bacteria, only F. nucleatum was universally found in all
16 samples (data not shown). F. nucleatum is a dominant
species in subgingival bioﬁlms in both healthy and disease
states, but is considered to be opportunistic pathogen in
polymicrobial infections such as bacterial vaginosis [37], acute
appendicitis [38], and anaerobic bacteraemia [39]. F. nucleatum
is also known as a bridging bacterium that facilitates bioﬁlm
formation [40]. The formation of polymicrobial bioﬁlm on the
bone surface has been observed in previous microscopic
investigations of osteomyelitis [41]. Other members of the
core microbiome (i.e. P. gingivalis and T. forthysia) are well-
known species that induce severe periodontitis with massive
bone resorption. Interestingly, a recent bioﬁlm study of
periodontal disease revealed that Fusobacterium induced bone
resorption synergistically with P. gingivalis and T. forthysia
[36,42]. Similarly, osteomyelitis is an infection in which a
bioﬁlm has formed and members of the core microbiome
interact to resist a variety of therapeutic interventions.
Although P. gingivalis and T. forthysia were also detected in
most samples (13 and eight, respectively), their abundances
were different, and their prevalence was relatively low in
several samples (0.04%), making them rare species in some
samples. As a possible explanation for this, the keystone-path-
ogen hypothesis has been proposed recently [43,44]. Accord-
ing to this hypothesis, even low-abundance species in bioﬁlms
can promote diseases as keystone pathogens, by remodelling
the usually benign microbiome into an imbalanced dis-
ease-causing one. To understand the roles of individual
bacterial species in this disease, further analyses, including
metagenomic and meta-transcriptomic approaches, will be
useful, and should provide more clues for the development of
new treatments. In addition, increasing the sample number of
each clinical type, with controlled states of the bone, will
provide better information on the characteristics and rela-
tionships of the microbiome in each clinical type, leading to the
development of novel preventions and cures.
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